Kurs
+1,21%
Kurs
+1,21%
Open
66,10
High
67,60
Low
65,00
Close
66,80
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
Est. tid* | ||
2026-02-25 | 07:00 | Bokslutskommuniké 2025 |
2025-11-26 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-08-27 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-05-28 | - | Kvartalsrapport 2025-Q1 |
2025-05-27 | - | X-dag ordinarie utdelning NYKD 1.00 NOK |
2025-05-26 | - | Årsstämma |
2025-04-23 | - | Extra Bolagsstämma 2025 |
2025-02-26 | - | Bokslutskommuniké 2024 |
2024-11-27 | - | Kvartalsrapport 2024-Q3 |
2024-08-21 | - | Kvartalsrapport 2024-Q2 |
2024-05-21 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2024-05-16 | - | Årsstämma |
2024-05-14 | - | Kvartalsrapport 2024-Q1 |
2024-02-28 | - | Bokslutskommuniké 2023 |
2023-11-15 | - | Kvartalsrapport 2023-Q3 |
2023-08-23 | - | Kvartalsrapport 2023-Q2 |
2023-05-16 | - | Kvartalsrapport 2023-Q1 |
2023-05-12 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2023-05-11 | - | Årsstämma |
2023-02-28 | - | Bokslutskommuniké 2022 |
2022-11-23 | - | Kvartalsrapport 2022-Q3 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-05-16 | - | Kvartalsrapport 2022-Q1 |
2022-05-13 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2022-05-12 | - | Årsstämma |
2022-03-31 | - | Bokslutskommuniké 2021 |
2021-12-22 | - | Extra Bolagsstämma 2021 |
2021-11-17 | - | Kvartalsrapport 2021-Q3 |
2021-08-26 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | Kvartalsrapport 2021-Q1 |
2021-05-06 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
2021-05-05 | - | Årsstämma |
2021-04-21 | - | Bokslutskommuniké 2020 |
2020-11-17 | - | Kvartalsrapport 2020-Q3 |
2020-08-27 | - | Kvartalsrapport 2020-Q2 |
2020-07-07 | - | Split NYKD 1:5 |
2020-07-06 | - | Extra Bolagsstämma |
2020-05-12 | - | Kvartalsrapport 2020-Q1 |
2020-04-22 | - | Extra Bolagsstämma |
Beskrivning
Land | Norge |
---|---|
Lista | Oslo Bors |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-11-02 16:39:54
Primary insider Christian Åbyholm, member of the board of Vaccibody AS,
represents Andenaesgruppen (including Kvantia AS and Christiania Skibs AS). In
order to streamline the ownership of Andenaesgruppen's shares in Vaccibody,
Kvantia AS has today sold 10,866,325 Vaccibody shares to Victoria India Fund AS
at NOK 64 per share. Furthermore, Christiania Skibs AS has today sold 6,304,250
Vaccibody shares to Victoria India Fund AS at NOK 64 per share. Victoria India
Fund AS is part of Andenaesgruppen and is 100% owned by Kvantia AS. After the
transaction Christian Åbyholm (board member) through Caaby AS holds 1,995,895
Vaccibody shares and 100,000 warrants and Andenaesgruppen (through Victoria
India Funds AS) represented by Christian Åbyholm owns 17,170,575 Vaccibody
shares and in addition Norda ASA represented by Christian Åbyholm owns 7,996,755
Vaccibody shares.
Please see further details in the attached document.